News

Acquisition enhances Lupin’s scale in the US generic market.

Company enhances immuno-oncology portfolio through strategic collaborations and acquisitions.

A diet high in refined carbohydrates may lead to an increased risk for new-onset depression in postmenopausal women, according to a study published in the American Journal of Clinical Nutrition.

A face-selective region has been identified in the temporal cortex of dogs.

A new study just published in the journal Molecular Psychiatry by the team led by Salah El Mestikawy, Ph.D., researcher at the Douglas Mental Health University Institute (CIUSSS de l'Ouest-de-l'île-de-Montréal), professor at McGill University in Montreal, Quebec and head of research at CNRS INSERM UPMC in Paris, opens the field to new understanding of the molecular mechanism underlying addiction in humans.

Trauma may cause distinct and long-lasting effects even in people who do not develop PTSD (post-traumatic stress disorder), according to research by scientists working at the University of Oxford's Department of Psychiatry.

It’s happy hour at a lab in College Station. The cocktail of choice, developed by scientists with Texas A&M AgriLife Research, is one that stops or prevents the deadly Pierce’s disease on wine grapes. The discovery could turn a new leaf on the multimillion-dollar U.S. wine industry.

Biotech del Norte distributes Company’s DNA, RNA and protein sequence analysis software in Mexico.

TxCell’s lead product designated for the treatment of moderate to severe Crohn’s disease.

The Washington Nanofabrication Facility is being developed to support start-ups and researchers who can not afford to invest high tech nano production equipment.